Effects of different arachidonic acid supplementation on psychomotor development in very preterm infants; a randomized controlled trial

Ayham Alshweki, Alejandro Pérez Muñuzuri, Ana M Baña, Ma José de Castro, Fernando Andrade, Luís Aldamiz-Echevarría, Miguel Sáenz de Pipaón, José M Fraga, María L Couce, Ayham Alshweki, Alejandro Pérez Muñuzuri, Ana M Baña, Ma José de Castro, Fernando Andrade, Luís Aldamiz-Echevarría, Miguel Sáenz de Pipaón, José M Fraga, María L Couce

Abstract

Background & aims: Nutritional supplementation with polyunsaturated fatty acids is important in preterm infants neurodevelopment, but it is not known if the omega-6/omega-3 ratio affects this process. This study was designed to determine the effects of a balanced contribution of arachidonic acid in very preterm newborns fed with formula milk.

Methods: This was a randomized trial, in which newborns <1500 g and/or <32 weeks gestational age were assigned to one of two groups, based on the milk formula they would receive during the first year of life. Initially, 60 newborns entered the study, but ultimately, group A was composed of 24 newborns, who were given formula milk with an ω-6/ω-3 ratio of 2/1, and Group B was composed of 21 newborns, given formula milk with an ω-6/ω-3 ratio of 1/1. The infants were followed up for two years: growth, visual-evoked potentials, brainstem auditory-evoked potentials, and plasma fatty acids were periodically measured, and psychomotor development was assessed using the Brunet Lézine scale at 24 months corrected age. A control group, for comparison of Brunet Lézine score, was made up of 25 newborns from the SEN1500 project, who were fed exclusively with breast milk.

Results: At 12 months, arachidonic acid values were significantly higher in group A than in group B (6.95 ± 1.55% vs. 4.55 ± 0.78%), as were polyunsaturated fatty acids (41.02 ± 2.09% vs. 38.08 ± 2.32%) achieved a higher average. Group A achieved a higher average Brunet Lézine score at 24 months than group B (99.9 ± 9 vs. 90.8 ± 11, p =0.028). The Brunet Lézine results from group A were compared with the control group results, with very similar scores registered between the two groups (99.9 ± 9 vs. 100.5 ± 7). There were no significant differences in growth or evoked potentials between the two formula groups.

Conclusions: Very preterm infants who received formula with an ω-6/ω-3 ratio of 2/1 had higher blood levels of essential fatty acids during the first year of life, and better psychomotor development, compared with very preterm newborns who consumed formula with an ω-6/ω-3 of 1/1. Therefore, formula milk with an arachidonic acid quantity double that of docosahexaenoic acid should be considered for feeding very preterm infants.

Trial registration: ClinicalTrials.gov Identifier NCT02503020.

Figures

Fig. 1
Fig. 1
Dietary intervention and follow-up of children during the first two years of life. CA, corerected age; IVH, intraventricular hemorrhage

References

    1. Gould JF, Smithers LG, Makrides M. The effect of maternal omega-3 LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2013;97:531–44. doi: 10.3945/ajcn.112.045781.
    1. Willatts P, Forsyth S, Agostani C, Casaer P, Riva E, Boehm G. Effects of long chain PUFA supplementation in infant formula on cognitive function in later childhood. Am J Clin Nutr. 2013;98(Suppl):536S–42S. doi: 10.3945/ajcn.112.038612.
    1. Jiao J, Li Q, Chu J, Zeng W, Yang M, Zhu S. Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;100(6):1422–36. doi: 10.3945/ajcn.114.095315.
    1. Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. Journal of the American Dietetic Association. 2009;109:668–679. doi: 10.1016/j.jada.2008.12.022.
    1. Sabel KG, Lundqvist-Persson C, Bona E, Petzold M, Strandvik B. Fatty acid patterns early after premature birth, simultaneously analyzed in mothers’ food, breast milk and serum phospholipids of mothers and infants. Lipids Health Dis. 2009;8:20. doi: 10.1186/1476-511X-8-20.
    1. Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr. 2007;137(4):855–9.
    1. Qawasmi A, Landeros-Weisenberger A, Leckman JF, Bloch MH. Meta-analysis of long-chain poly unsaturated fatty acid supplementation of formula and infant cognition. Pediatrics. 2012;129:1141–9. doi: 10.1542/peds.2011-2127.
    1. CL S n, Oliver JS, Marriage BJ. Docosahexaenoic acid supplementation in lactating women increases breast milk and plasma docosahexaenoic acid concentrations and alters infant omega 6:3 fatty acid ratio. Prostaglandins Leukot Essent Fatty Acids. 2015;95:63–9. doi: 10.1016/j.plefa.2015.01.005.
    1. Innis SM. Human milk and formula fatty acids. J Pediatr. 1992;120:S56–61. doi: 10.1016/S0022-3476(05)81237-5.
    1. Anderson JW, Johnston BM, Remley DT. Breast feeding and cognitive development: a meta-analysis. Am J Clin Nutr. 1999;70:525–35.
    1. Arterburn L, Bailey Hall E, Oken H. Distribution, and dose response of n-3 fatty acids in humans. Am J ClinNutr. 2006;83(Suppl):1467S–1476S.
    1. Clandinin MT, Van Aerde JE, Merkel KL. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr. 2005;146(4):461–468. doi: 10.1016/j.jpeds.2004.11.030.
    1. O'Connor DL, Hall R, Adamkin D, Auestad N, Castillo M, Connor WE. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics. 2001;108(2):359–71. doi: 10.1542/peds.108.2.359.
    1. Meldrum SJ, D'Vaz N, Simmer K, Dunstan JA, Hird K, Prescott SL. Effect of high dose fish oil supplementation during earlyinfancy on neurodevelopment and language: a randomized controlled trial. Br J Nutr. 2012;108:1443–54. doi: 10.1017/S0007114511006878.
    1. Fukaya T, Gondaira T, Kashiyae Y, Kotani S, Ishikura Y, Fujikawa S, et al. Arachidonic acid preserves hippocampal neuron membrane fluidity in senescent rats. Neurobiol Aging. 2007;28(8):1179–1186. doi: 10.1016/j.neurobiolaging.2006.05.023.
    1. Wang ZJ, Liang CL, Li GM, Yu CY, Yin M. Neuroprotective effects of arachidonic acid against oxidative stress on rat hippocampal slices. Chem Biol Interact. 2006;163(3):207–17. doi: 10.1016/j.cbi.2006.08.005.
    1. Darios F, Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature. 2006;440(7085):813–7. doi: 10.1038/nature04598.
    1. Birch Eileen E, Garfield S, Hoffman Dennis R, Uauy R, Birch David G. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2007;42(3):174. doi: 10.1111/j.1469-8749.2000.tb00066.x.
    1. Muller H, Kirkhus B, Pedersen JI. Serum cholesterol predictive equations with special emphasis on trans and saturated fatty acids. Analysis from designed controlled studies. Lipids. 2001;36:783–791. doi: 10.1007/s11745-001-0785-6.
    1. Simopoulos AP. Genetic variants in the metabolism of omega- 6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp Biol Med. 2010;235:785–795. doi: 10.1258/ebm.2010.009298.
    1. Bauer J, Gerss J. Longitudinal analysis of macronutrients and minerals in human milk produced by mothers of preterm infants. Clin Nutr. 2011;30(2):215–220. doi: 10.1016/j.clnu.2010.08.003.
    1. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lip Res. 1986;27:114–120.
    1. Brunet O, Lézine I, Josse D. Brunet-Lézine Révisé: échelle de développement psychomoteur de la première enfance. Paris: Manuel BLR-C; 1997.
    1. Otten JJ, Hellwig JP, Meyers LD. Institute of Medicine: dietary reference intakes: the essential guide to nutrient requirements. Washington, DC: National Academies Press; 2006.
    1. Agostoni C, Buonocore G, Carnielli VP. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastro Eenterol Nutr. 2010;50:85. doi: 10.1097/MPG.0b013e3181adaee0.
    1. Colombo J, Carlson SE, Cheatham CL, Shaddy DJ, Kerling EH, Thodosoff JM, et al. Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr. 2013;98:403–12. doi: 10.3945/ajcn.112.040766.
    1. Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr. 2007;85:1457–64.
    1. Aydin İ, Turan Ö, Aydin FN, Koç E, Hirfanoğlu İM, Akyol M, et al. Comparing the fatty acid levels of preterm and term breast milk in Turkish women. Turk J Med Sci. 2014;44:305–310. doi: 10.3906/sag-1302-131.
    1. Yuhas R, Pramuk K, Eric L, Lien EL. Human milk fatty Acid composition from nine countries varies most in DHA. Lipids. 2006;41:851–858. doi: 10.1007/s11745-006-5040-7.
    1. Bradbury J. Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain. Nutrients. 2011;3(5):529–554. doi: 10.3390/nu3050529.
    1. Makrides M, Collins CT, Gibson RA. Impact of fatty acid status on growth and neurobehavioural development in humans. Maternal and Child Nutrition. 2011;7(2):80–88. doi: 10.1111/j.1740-8709.2011.00304.x.
    1. Ricardo U, Hoffman DR. Essential fat requirements of preterm infants. Am J ClinNutr. 2000;71(suppl):245S–50S.
    1. Faldella G, Govoni M, Alessandroni R, Marchiani E, Salvioli GP, Biagi PL, et al. Visual evoked potentials and dietary long chain polyunsaturated fatty acids in preterm infants. Arch Dis Child. 1996;75:F108–12. doi: 10.1136/fn.75.2.F108.
    1. Braveman PA, Heck K, Egerter S, Marchi KS, Dominguez TP. The role of socioeconomic factors in Black-White disparities in preterm birth. Am J Public Health. 2015;105(4):694–702. doi: 10.2105/AJPH.2014.302008.
    1. Rahkonen P, Heinonen K, Pesonen AK, Lano A, Autti T. Mother-child interaction is associated with neurocognitive outcome in extremely low gestational age children. Scand J Psychol. 2014;55(4):311–8. doi: 10.1111/sjop.12133.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe